ConductScience.org, home

Paper29241971

Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery.

Ma J and 9 others. Mol Ther, 2018. Cited by 38 papers, by iCite.

Cite this record

ConductScience Library. Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery. Papers, record 29241971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29241971

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery.
PubMed
Journal
Mol Ther
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
38
iCite
Relative citation ratio, by iCite
1.45
iCite
Revised in PubMed
2019-01-15
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ma JJing
2Kala SShashwati
3Yung SSusan
4Chan TMTak Mao
5Cao YYu
6Jiang YYifan
7Liu XXiaoxuan
8Giorgio SSuzanne
9Peng LLing
10Wong ASTAlice S T

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DendrimersMajor topic
Gene Transfer TechniquesMajor topic
Neoplastic Stem CellsMajor topic
Ovarian NeoplasmsMajor topic
RNA, Small InterferingMajor topic
Ribosomal Protein S6 Kinases, 70-kDaMajor topic
Animals
Cell Adhesion
Cell Movement
Cell Proliferation
Disease Models, Animal
Female
Humans
Mice
RNA Interference
RNA Stability
Recurrence
Theranostic Nanomedicine

Source PubMed

Download CSV of topics

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127009393Targeting metastasis.Nat Rev Cancer2016https://conductscience.org/library/papers/27009393PubMed
223097117Human female reproductive tract epithelial cell culture.Methods Mol Biol2013https://conductscience.org/library/papers/23097117PubMed
315520168Mutation of the PIK3CA gene in ovarian and breast cancer.Cancer Res2004https://conductscience.org/library/papers/15520168PubMed
424592939
Combination of dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating ovarian cancer.
J Med Chem2014https://conductscience.org/library/papers/24592939PubMed
521952167Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.Mol Ther2011https://conductscience.org/library/papers/21952167PubMed
627244195Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing.Small2016https://conductscience.org/library/papers/27244195PubMed
723929703Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.Hepatology2014https://conductscience.org/library/papers/23929703PubMed
824965758Targeted delivery of Dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system.Nanomedicine2014https://conductscience.org/library/papers/24965758PubMed
916469801Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells.Endocrinology2006https://conductscience.org/library/papers/16469801PubMed
102946403A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.Cancer Res1986https://conductscience.org/library/papers/2946403PubMed
1120651229Ovarian cancer development and metastasis.Am J Pathol2010https://conductscience.org/library/papers/20651229PubMed
1219328215Lipid-based systemic delivery of siRNA.Adv Drug Deliv Rev2009https://conductscience.org/library/papers/19328215PubMed
1312529391Protein kinase C phosphorylates ribosomal protein S6 kinase betaII and regulates its subcellular localization.Mol Cell Biol2003https://conductscience.org/library/papers/12529391PubMed
1422820909The pharmacology and therapeutic potential of small molecule inhibitors of acid-sensing ion channels in stroke intervention.Acta Pharmacol Sin2013https://conductscience.org/library/papers/22820909PubMed
1525749385G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.Oncotarget2015https://conductscience.org/library/papers/25749385PubMed
167509044A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.Nature1994https://conductscience.org/library/papers/7509044PubMed
1715100358Reduction of perlecan synthesis and induction of TGF-beta1 in human peritoneal mesothelial cells due to high dialysate glucose concentration: implication in peritoneal dialysis.J Am Soc Nephrol2004https://conductscience.org/library/papers/15100358PubMed
1822692575Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.Mol Med2012https://conductscience.org/library/papers/22692575PubMed
1921602892Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR.Oncogene2011https://conductscience.org/library/papers/21602892PubMed
207923380Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression.Cell1994https://conductscience.org/library/papers/7923380PubMed

See all 46 referencesDownload CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.

PMIDTitleJournalYearIn PapersSource
42458028Precision chemical engineering of dendrimers for nucleic acid delivery.Nat Rev Chem2026https://conductscience.org/library/papers/42458028PubMed
41779311Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions.Discov Nano2026https://conductscience.org/library/papers/41779311PubMed
40178336Emerging dendrimer-based RNA delivery strategies.Nanomedicine (Lond)2025https://conductscience.org/library/papers/40178336PubMed
40142941Targeting Cancer Stemness Using Nanotechnology in a Holistic Approach: A Narrative Review.Pharmaceutics2025https://conductscience.org/library/papers/40142941PubMed
38955927Advances in ovarian tumor stem cells and therapy.Cell Biochem Biophys2024https://conductscience.org/library/papers/38955927PubMed
37518857Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers.Small2024https://conductscience.org/library/papers/37518857PubMed
37511335Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells.Int J Mol Sci2023https://conductscience.org/library/papers/37511335PubMed
36495345B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.Cell Mol Life Sci2022https://conductscience.org/library/papers/36495345PubMed
36360633The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities.Int J Environ Res Public Health2022https://conductscience.org/library/papers/36360633PubMed
35879299Beyond controlling cell size: functional analyses of S6K in tumorigenesis.Cell Death Dis2022https://conductscience.org/library/papers/35879299PubMed
35582568Circulating non-coding RNAs in recurrent and metastatic ovarian cancer.Cancer Drug Resist2019https://conductscience.org/library/papers/35582568PubMed
35456698Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials.Pharmaceutics2022https://conductscience.org/library/papers/35456698PubMed
35046650Chitosan-Coated-PLGA Nanoparticles Enhance the Antitumor and Antimigration Activity of Stattic - A STAT3 Dimerization Blocker.Int J Nanomedicine2022https://conductscience.org/library/papers/35046650PubMed
34959397Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective.Pharmaceutics2021https://conductscience.org/library/papers/34959397PubMed
34641519Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.Molecules2021https://conductscience.org/library/papers/34641519PubMed
34249406Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs.Am J Cancer Res2021https://conductscience.org/library/papers/34249406PubMed
34052831Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties.Cell Death Dis2021https://conductscience.org/library/papers/34052831PubMed
33841626Paving the way for small-molecule drug discovery.Am J Transl Res2021https://conductscience.org/library/papers/33841626PubMed
33828085Silencing PTEN in the fallopian tube promotes enrichment of cancer stem cell-like function through loss of PAX2.Cell Death Dis2021https://conductscience.org/library/papers/33828085PubMed
33532180Recent advances in drug delivery systems for targeting cancer stem cells.Acta Pharm Sin B2021https://conductscience.org/library/papers/33532180PubMed

See all 24 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RPS6KB16198PubTator's text mininghttps://conductscience.org/library/genes/6198

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29241971

GET https://conductscience.org/api/papers/v1/29241971/references?page=2